Hyphema
Symptoms, Doctors, Treatments, Advances & More

Learn About Hyphema

What is the definition of Hyphema?

Hyphema is blood in the front area (anterior chamber) of the eye. The blood collects behind the cornea and in front of the iris.

What are the causes of Hyphema?

Hyphema is most often caused by trauma to the eye. Other causes of bleeding in the front chamber of the eye include:

  • Blood vessel abnormality
  • Cancer of the eye
  • Severe inflammation of the iris
  • Advanced diabetes
  • Blood disorders such as sickle cell anemia
What are the symptoms of Hyphema?

Symptoms include:

  • Bleeding in the anterior chamber of the eye
  • Eye pain
  • Light sensitivity
  • Vision abnormalities

You may not be able to see a small hyphema when looking at your eye in the mirror. With a total hyphema, the collection of blood will block the view of the iris and pupil.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyphema?

Treatment may not be needed in mild cases. The blood is absorbed in a few days.

The outcome of the condition will likely be much worse if bleeding comes back or worsens, especially within 3 to 5 days. The health care provider may recommend the following to cut down the chance that there will be more bleeding:

  • Bed rest
  • Eye patching
  • Sedating medicines

You may need to use eye drops to decrease the inflammation or lower the pressure in your eye.

An eye doctor may need to remove the blood surgically, especially if pressure in the eye is very high or the blood is slow to absorb again. You may need to stay in a hospital.

Who are the top Hyphema Local Doctors?
Elite in Hyphema
Family Medicine
Elite in Hyphema
Family Medicine

UPMC Mckeesport

2347 5th Ave, 
Mckeesport, PA 
Languages Spoken:
English

Olumuyiwa Adebona is a primary care provider, practicing in Family Medicine in Mckeesport, Pennsylvania. Dr. Adebona is rated as an Elite provider by MediFind in the treatment of Hyphema. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Hyphema, Avian Influenza, Flu, and Chronic Obstructive Pulmonary Disease (COPD).

Elite in Hyphema
Elite in Hyphema
Referral may be required
Al Mansurah, DK, EG 

Ahmed Elwehidy practices practicing medicine in Al Mansurah, Egypt. Mr. Elwehidy is rated as an Elite expert by MediFind in the treatment of Hyphema. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hyphema, Ocular Hypertension (OHT), Glaucoma, Trabeculectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hyphema
Elite in Hyphema
Referral may be required
State Key Laboratory Of Ophthalmology, Guangdong Provincial Key Laboratory Of Ophthalmology And Visual Science, 
Guangzhou, CN 

Fengbin Lin practices practicing medicine in Guangzhou, China. Lin is rated as an Elite expert by MediFind in the treatment of Hyphema. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Hyphema, Ocular Hypertension (OHT), Glaucoma, Trabeculectomy, and Iridectomy.

What is the outlook (prognosis) for Hyphema?

The outcome depends upon the amount of injury to the eye. People with sickle cell disease are more likely to have eye complications and must be watched closely. People with diabetes will probably need laser treatment for the problem.

Severe vision loss can occur.

What are the possible complications of Hyphema?

Complications may include:

  • Acute glaucoma
  • Impaired vision
  • Recurring bleeding
When should I contact a medical professional for Hyphema?

Contact your provider if you notice blood in the front of the eye or if you have an eye injury. You will need to be examined and treated by an eye doctor right away, especially if you have decreased vision.

How do I prevent Hyphema?

Many eye injuries can be prevented by wearing safety goggles or other protective eyewear. Always wear eye protection while playing sports, such as racquetball, or contact sports, such as basketball.

What are the latest Hyphema Clinical Trials?
Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye

Summary: This is a multi-center, cross-sectional study evaluating a smartphone-based artificial intelligence (AI) system for anterior segment eye disease screening. The system is designed to identify 16 clinically important anterior segment conditions from images captured using a standard Android smartphone. A core design feature of the system is that all image analysis is performed entirely on the smartph...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Preserflo MicroShunt Implantation Versus Trabeculectomy in Managing Open-Angle Glaucoma

Summary: The goal of this randomized controlled clinical trial is to learn whether two minimally invasive bleb-forming glaucoma implants can effectively treat adult patients with open-angle glaucoma who require surgical lowering of intraocular pressure (IOP). Specifically, the study evaluates whether the PRESERFLO™ MicroShunt is at least as effective as the trabeculectomy in reducing IOP after surgery. The...

What are the Latest Advances for Hyphema?
Who are the sources who wrote this article ?

Published Date: October 02, 2024
Published By: Audrey Tai, DO, MS, Athena Eye Care, Mission Viejo, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Lin TKY, Tingey DP, Shingleton BJ. Glaucoma associated with ocular trauma. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 10.16.

Olitsky SE, Marsh JD. Injuries to the eye. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 675.

Patel S, Kim SJ, Sternberg P. Surgery for ocular trauma: principles and techniques of treatment. In: Sadda SVR, Sarraf D, Freund B, et al, eds. Ryan's Retina. 7th ed. Philadelphia, PA: Elsevier; 2023:chap 113.